Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Redx Pharma Gelecekteki Büyüme
Future kriter kontrolleri 0/6
Redx Pharma's revenue and earnings are forecast to decline at 37.6% and 22.3% per annum respectively while EPS is expected to decline by 14.2% per annum.
Anahtar bilgiler
-22.3%
Kazanç büyüme oranı
-14.2%
EPS büyüme oranı
Pharmaceuticals kazanç büyümesi | 16.3% |
Gelir büyüme oranı | -37.6% |
Gelecekteki özkaynak getirisi | n/a |
Analist kapsamı | Low |
Son güncelleme | 02 Apr 2024 |
Kazanç ve Gelir Büyüme Tahminleri
Tarih | Gelir | Kazançlar | Serbest Nakit Akışı | Faaliyetlerden Nakit | Avg. Analist Sayısı |
---|---|---|---|---|---|
9/30/2025 | N/A | -49 | N/A | -48 | 1 |
9/30/2024 | 13 | -26 | N/A | -24 | 1 |
9/30/2023 | 4 | -33 | -35 | -35 | N/A |
6/30/2023 | 8 | -31 | -32 | -32 | N/A |
3/31/2023 | 13 | -29 | -30 | -30 | N/A |
12/31/2022 | 16 | -24 | -19 | -19 | N/A |
9/30/2022 | 19 | -18 | -9 | -8 | N/A |
6/30/2022 | 17 | -18 | -8 | -8 | N/A |
3/31/2022 | 16 | -19 | -8 | -7 | N/A |
12/31/2021 | 13 | -20 | -15 | -14 | N/A |
9/30/2021 | 10 | -22 | -22 | -21 | N/A |
6/30/2021 | 8 | -20 | -15 | -14 | N/A |
3/31/2021 | 7 | -18 | -7 | -7 | N/A |
12/31/2020 | 6 | -14 | -4 | -3 | N/A |
9/30/2020 | 6 | -9 | 0 | 0 | N/A |
6/30/2020 | 5 | -8 | -2 | -2 | N/A |
3/31/2020 | 4 | -6 | -5 | -5 | N/A |
12/31/2019 | 4 | -5 | -5 | -5 | N/A |
9/30/2019 | 3 | -4 | -5 | -5 | N/A |
6/30/2019 | 2 | -5 | -6 | -6 | N/A |
3/31/2019 | N/A | -7 | -8 | -8 | N/A |
12/31/2018 | 0 | -8 | -13 | -13 | N/A |
9/30/2018 | 0 | -9 | -17 | -17 | N/A |
6/30/2018 | 15 | -1 | -4 | -4 | N/A |
3/31/2018 | 31 | 8 | 9 | 9 | N/A |
12/31/2017 | 31 | 5 | 11 | 11 | N/A |
9/30/2017 | 30 | 2 | 14 | 14 | N/A |
6/30/2017 | 15 | -9 | N/A | -1 | N/A |
3/31/2017 | N/A | -19 | N/A | -16 | N/A |
12/31/2016 | N/A | -17 | N/A | -14 | N/A |
9/30/2016 | N/A | -16 | N/A | -13 | N/A |
6/30/2016 | N/A | -14 | N/A | -11 | N/A |
3/31/2016 | N/A | -12 | N/A | -9 | N/A |
12/31/2015 | N/A | -10 | N/A | -8 | N/A |
9/30/2015 | N/A | -8 | N/A | -7 | N/A |
6/30/2015 | N/A | -7 | N/A | -6 | N/A |
3/31/2015 | N/A | -5 | N/A | -5 | N/A |
12/31/2014 | N/A | -4 | N/A | -4 | N/A |
9/30/2014 | N/A | -3 | N/A | -2 | N/A |
Analist Gelecek Büyüme Tahminleri
Kazançlar ve Tasarruf Oranları: REDX is forecast to remain unprofitable over the next 3 years.
Kazançlar ve Piyasa: REDX is forecast to remain unprofitable over the next 3 years.
Yüksek Büyüme Kazançları: REDX is forecast to remain unprofitable over the next 3 years.
Gelir ve Pazar: REDX's revenue is expected to decline over the next 3 years (-37.6% per year).
Yüksek Büyüme Geliri: REDX's revenue is forecast to decline over the next 3 years (-37.6% per year).
Hisse Başına Kazanç Büyüme Tahminleri
Gelecekteki Özkaynak Getirisi
Gelecekteki ROE: Insufficient data to determine if REDX's Return on Equity is forecast to be high in 3 years time